News, product updates, clinical research, and perspectives on building reliable, evidence-based mental health care.
MedLink Global, which developed an AI-assisted psychiatric platform for patient intake and assessing and quantifying the severity and complexity of symptoms, announced its product has officially been qualified as a solution for the Mayo Clinic Platform — Mayo Clinic’s initiative to drive healthcare innovation through the use of AI and digital solutions.
Dr. Stephen M. Stahl and Dr. Christoph Correll will work through real-world patient profiles as treating psychiatrists, comparing their live clinical decisions with Comentra's automated treatment suggestions and underlying logic.
The MedLink Psychiatric solution is designed to support clinicians with structured psychiatric assessment, measurement-based care, and longitudinal symptom tracking
Join Dr. Mark Blais for an interactive case review to master interpreting the MaiNDS evaluation framework. Learn step-by-step how to move beyond raw scores, connecting quantitative data directly to deeper patient insights and actionable treatment plans.
New ADHD insights: 10% of children, 4% adults affected. Key case studies on medication challenges & comprehensive treatment approaches.
We're thrilled to announce that MedLink Global is now available on the athenahealth Marketplace, making it easier than ever for healthcare providers to access our solutions.
Anxiety disorders affect 24% of US adults. Dr. Jeffrey Strawn shares evidence-based treatment strategies, from SSRIs to CBT exposure therapy.
Revolutionary MaiNDS assessment bridges DSM & modern research. Dr. Mark Blais unveils transdiagnostic approach transforming mental health evaluation.
Schizophrenia breakthrough: Move beyond dopamine! New muscarinic treatments like KarXT show promising results. Paradigm shift in progress.
Depression revolution: After 60 years of SSRIs, breakthrough treatments offer rapid relief. Ketamine, psychedelics changing lives.
